<DOC>
	<DOCNO>NCT01048372</DOCNO>
	<brief_summary>Primary Objective : To determine mechanism Cytolin 's effect HIV replication blood draw HIV-positive HIV-negative individual exposure Cytolin .</brief_summary>
	<brief_title>Observational Study Blood Treated With Cytolin</brief_title>
	<detailed_description>The initial phase vitro study regard potential mechanism action Cytolin complete January 2011 . Given data set date , decision make extend study . The extension allow Company confirm extend initial finding regard potential mechanism action Cytolin .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Early HIV Infection HIV seropositive viral load &lt; 100,000 copies/ml CD4+ &gt; 350 cells/ul Ability willingness give write informed consent . Control Group HIV seronegative subject identify HIV uninfected nonreactive HIV 1/2 ELISA . Ability willingness give write informed consent . Presentation opportunistic infection AIDSdefining illness . Receipt investigational research agent within 30 day prior study entry . Prior receipt experimental HIV vaccine , sham vector adjuvant . Receipt immunosuppressive medication immune modulators within past six month . Individuals take corticosteroid nasal spray allergic rhinitis , topical steroid counter medication acute , uncomplicated dermatitis period longer 14 day exclude . Active drug alcohol use , dependence psychiatric illness opinion study investigator would interfere adherence study protocol . Serious illness require hospitalization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>monoclonal antibody</keyword>
	<keyword>immune therapy</keyword>
	<keyword>pathogenesis</keyword>
	<keyword>cytotoxic T lymphocyte</keyword>
	<keyword>anti-CD4</keyword>
	<keyword>anti-self</keyword>
	<keyword>viral replication</keyword>
	<keyword>Acute Infection</keyword>
</DOC>